Styrene

Styrene

SCHEMBL3545858

C=Cc1ccccc1.C=Cc1ccccc1C.C=Cc1ccccc1C(=O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
TSHR P16473 2/20 0.44
MYC P01106 2/20 0.42
HPGD P15428 3/20 0.42
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 2/20 0.42
PKM P14618 1/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 3/20 0.40
GLO1 Q04760 1/20 0.40
POLB P06746 1/20 0.40
ALOX15 P16050 1/20 0.39
HTT P42858 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NR4A1 P22736 1/20 0.39
MCL1 Q07820 1/20 0.39
MEN1 O00255 1/20 0.39
AKR1B10 O60218 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17668258 0.94 MYC (0.47) ALDH1A1TSHRMYCHPGDKDM4E
Styrene SCHEMBL2118111 0.90 ALDH1A1 (0.54) ALDH1A1TSHRHPGDKDM4EHSD17B10
Styrene SCHEMBL28935148 0.87 ALDH1A1 (0.50) ALDH1A1TSHRHPGDKDM4EHSD17B10
SCHEMBL7931668 0.86 AKR1C3 (0.47) ALDH1A1TSHRHPGDKDM4ECYP3A4
Styrene SCHEMBL27882135 0.85 ALDH1A1 (0.61) ALDH1A1TSHRKDM4EKMT2AL3MBTL1
Styrene SCHEMBL139395 0.85 ALDH1A1 (0.61) ALDH1A1TSHRKDM4EKMT2AL3MBTL1
Styrene SCHEMBL27730063 0.83 ALDH1A1 (0.58) ALDH1A1TSHRKDM4EKMT2AL3MBTL1
SCHEMBL30259301 0.83 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EHSD17B10CYP2C9
Benzene SCHEMBL28254104 0.83 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EHSD17B10CYP2C9
SCHEMBL31100 0.83 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EHSD17B10CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728139-B2 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives MCA TECHNOLOGIES GMBH (CH) 2010-06-01 US disclosed
EP-1603913-B1 SOLVENT-FREE PROCESS FOR THE PREPARATION OF DIKETOPYRROLOPYRROLE DERIVATIVES MCA TECHNOLOGIES GMBH (CH) 2008-11-26 EP disclosed
US-20060246023-A1 for use as latent pigments; photocopiers MCA TECHNOLOGIES GMBH (CH) 2006-11-02 US disclosed
EP-1603913-A1 SOLVENT-FREE PROCESS FOR THE PREPARATION OF DIKETOPYRROLOPYRROLE DERIVATIVES MCA Technologies GMBH (CH) 2005-12-14 EP disclosed
WO-2004076456-A1 SOLVENT-FREE PROCESS FOR THE PREPARATION OF DIKETOPYRROLOPYRROLE DERIVATIVES MCA TECHNOLOGIES GMBH (CH) 2004-09-10 WO disclosed
US-6211347-B1 INKS, COLOR FILTERS CIBA SPECIALTY CHEMICALS CORPORATION 2001-04-03 US disclosed
US-6071989-A MIXING LATENT PIGMENT, POLYMER AND SOLVENT; REMOVING SOLVENT; SUBJECTING SOLVENT-FREE MIXTURE TO THERMAL, CHEMICAL OR PHOTOLYTIC TREATMENT; ADDING SOLVENT TO TREATED MIXTURE CIBA SPECIALTY CHEMICALS CORPORATION (US) 2000-06-06 US disclosed
US-6001168-A Pigment dispersions comprising C.I. Pigment Red 222 CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060246023-A1 for use as latent pigments; photocopiers XPA, PPOX, ALDH1A2 ALDH1A1 314/4885TSHR 4257/4885MYC 3611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.